Adma Biologics(ADMA.US)

Last Updated 19:00:00 ET
longbridge loading

17:28 ETRosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA

prnewswire·
US
ADMA
+0.68%
prnewswire·
US
ADMA
+0.68%

20:15 ETINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA

prnewswire·
US
ADMA
+0.68%
US
VHT
-0.12%
US
XLV
-0.44%
prnewswire·
US
ADMA
+0.68%
US
VHT
-0.12%
US
XLV
-0.44%

A Look At ADMA Biologics (ADMA) Valuation After Short Seller Allegations And Legal Investigations

Simplywall·
US
ADMA
+0.68%
US
IBB
+1.56%
US
SBIO
+2.76%
Simplywall·
US
ADMA
+0.68%
US
IBB
+1.56%
US
SBIO
+2.76%

Innovent to Present Multiple Clinical and Preclinical Results of Mazdutide and Next-Generation Obesity & Metabolic Pipeline at the 2026 ADA Scientific Sessions

Unusual Whales·
SZ
159892
-0.71%
SH
589720
+1.03%
SZ
159615
-0.30%
Unusual Whales·
SZ
159892
-0.71%
SH
589720
+1.03%
SZ
159615
-0.30%

17:24 ETRosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA

prnewswire·
US
ADMA
+0.68%
US
IBBQ
+1.65%
US
FBT
+1.23%
prnewswire·
US
ADMA
+0.68%
US
IBBQ
+1.65%
US
FBT
+1.23%

03:18 ETRosen Law Firm Encourages ADMA Biologics, Inc. Investors to Inquire About Securities Class Action Investigation - ADMA

prnewswire·
US
ADMA
+0.68%
US
XBI
+2.99%
US
BBH
+0.22%
prnewswire·
US
ADMA
+0.68%
US
XBI
+2.99%
US
BBH
+0.22%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

benzinga_article·
US
TRDA
+4.96%
US
AGL
-0.85%
US
ATRA
-3.72%
benzinga_article·
US
TRDA
+4.96%
US
AGL
-0.85%
US
ATRA
-3.72%

Adma Biologics | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 114.49 M

Earnings Watch·
US
ADMA
+0.68%
Earnings Watch·
US
ADMA
+0.68%

ADMA (ADMA) Q1 2026 Earnings Transcript

nasdaq·
US
ADMA
+0.68%
US
XBI
+2.99%
US
IBBQ
+1.65%
nasdaq·
US
ADMA
+0.68%
US
XBI
+2.99%
US
IBBQ
+1.65%

ADMA Biologics shares are trading lower after the company reported worse-than-expected Q1 financial results and issued FY26 sales guidance below estimates.

benzinga_article·
US
ADMA
+0.68%
benzinga_article·
US
ADMA
+0.68%
© 2026 Longbridge｜Disclaimer